705 related articles for article (PubMed ID: 16481920)
61. Advances in low-frequency ultrasound combined with microbubbles in targeted tumor therapy.
Wang LY; Zheng SS
J Zhejiang Univ Sci B; 2019 Apr.; 20(4):291-299. PubMed ID: 30932374
[TBL] [Abstract][Full Text] [Related]
62. Ultrasound contrast agents and ultrasound molecular imaging.
Wen Q; Wan S; Liu Z; Xu S; Wang H; Yang B
J Nanosci Nanotechnol; 2014 Jan; 14(1):190-209. PubMed ID: 24730259
[TBL] [Abstract][Full Text] [Related]
63. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I--Formulation development and in-vitro characterization.
Tinkov S; Winter G; Coester C; Bekeredjian R
J Control Release; 2010 Apr; 143(1):143-50. PubMed ID: 20060861
[TBL] [Abstract][Full Text] [Related]
64. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
Willmann JK; Paulmurugan R; Chen K; Gheysens O; Rodriguez-Porcel M; Lutz AM; Chen IY; Chen X; Gambhir SS
Radiology; 2008 Feb; 246(2):508-18. PubMed ID: 18180339
[TBL] [Abstract][Full Text] [Related]
65. VEGFR2-targeted molecular imaging in the mouse embryo: an alternative to the tumor model.
Denbeigh JM; Nixon BA; Hudson JM; Puri MC; Foster FS
Ultrasound Med Biol; 2014 Feb; 40(2):389-99. PubMed ID: 24342913
[TBL] [Abstract][Full Text] [Related]
66. Focused in vivo delivery of plasmid DNA to the porcine vascular wall via intravascular ultrasound destruction of microbubbles.
Phillips LC; Klibanov AL; Bowles DK; Ragosta M; Hossack JA; Wamhoff BR
J Vasc Res; 2010; 47(3):270-4. PubMed ID: 19923850
[TBL] [Abstract][Full Text] [Related]
67. Sustained transgene expression in intervertebral disc cells in vivo mediated by microbubble-enhanced ultrasound gene therapy.
Nishida K; Doita M; Takada T; Kakutani K; Miyamoto H; Shimomura T; Maeno K; Kurosaka M
Spine (Phila Pa 1976); 2006 Jun; 31(13):1415-9. PubMed ID: 16741448
[TBL] [Abstract][Full Text] [Related]
68. Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi.
Schumann PA; Christiansen JP; Quigley RM; McCreery TP; Sweitzer RH; Unger EC; Lindner JR; Matsunaga TO
Invest Radiol; 2002 Nov; 37(11):587-93. PubMed ID: 12393970
[TBL] [Abstract][Full Text] [Related]
69. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.
Ellegala DB; Leong-Poi H; Carpenter JE; Klibanov AL; Kaul S; Shaffrey ME; Sklenar J; Lindner JR
Circulation; 2003 Jul; 108(3):336-41. PubMed ID: 12835208
[TBL] [Abstract][Full Text] [Related]
70. Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals.
Schutt EG; Klein DH; Mattrey RM; Riess JG
Angew Chem Int Ed Engl; 2003 Jul; 42(28):3218-35. PubMed ID: 12876730
[TBL] [Abstract][Full Text] [Related]
71. Enhanced delivery of microRNA mimics to cardiomyocytes using ultrasound responsive microbubbles reverses hypertrophy in an in-vitro model.
Gill SL; O'Neill H; McCoy RJ; Logeswaran S; O'Brien F; Stanton A; Kelly H; Duffy GP
Technol Health Care; 2014; 22(1):37-51. PubMed ID: 24398813
[TBL] [Abstract][Full Text] [Related]
72. Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery.
Liu Y; Miyoshi H; Nakamura M
J Control Release; 2006 Aug; 114(1):89-99. PubMed ID: 16824637
[TBL] [Abstract][Full Text] [Related]
73. Combined effect of ultrasound/SonoVue microbubble on CD4(+)CD25(+) regulatory T cells viability and optimized parameters for its transfection.
Shi C; Zhang Y; Yang H; Dong T; Chen Y; Xu Y; Yang X
Ultrasonics; 2015 Sep; 62():97-102. PubMed ID: 26048174
[TBL] [Abstract][Full Text] [Related]
74. Detection of individual microbubbles of ultrasound contrast agents: imaging of free-floating and targeted bubbles.
Klibanov AL; Rasche PT; Hughes MS; Wojdyla JK; Galen KP; Wible JH; Brandenburger GH
Invest Radiol; 2004 Mar; 39(3):187-95. PubMed ID: 15076011
[TBL] [Abstract][Full Text] [Related]
75. Targeted microbubbles in the experimental and clinical setting.
Alzaraa A; Gravante G; Chung WY; Al-Leswas D; Bruno M; Dennison AR; Lloyd DM
Am J Surg; 2012 Sep; 204(3):355-66. PubMed ID: 22920405
[TBL] [Abstract][Full Text] [Related]
76. A Review of Phospholipid Encapsulated Ultrasound Contrast Agent Microbubble Physics.
Helfield B
Ultrasound Med Biol; 2019 Feb; 45(2):282-300. PubMed ID: 30413335
[TBL] [Abstract][Full Text] [Related]
77. Safety of Image-Guided Treatment of the Liver with Ultrasound and Microbubbles in an in Vivo Porcine Model.
Keller SB; Wang YN; Totten S; Yeung RS; Averkiou MA
Ultrasound Med Biol; 2021 Nov; 47(11):3211-3220. PubMed ID: 34362584
[TBL] [Abstract][Full Text] [Related]
78. Ultrasound-directed drug delivery.
Postema M; Gilja OH
Curr Pharm Biotechnol; 2007 Dec; 8(6):355-61. PubMed ID: 18289044
[TBL] [Abstract][Full Text] [Related]
79. The Preparation of Chicken Ex Ovo Embryos and Chorioallantoic Membrane Vessels as In Vivo Model for Contrast-Enhanced Ultrasound Imaging and Microbubble-Mediated Drug Delivery Studies.
Meijlink B; Skachkov I; van der Steen AFW; de Jong N; Kooiman K
J Vis Exp; 2021 Feb; (168):. PubMed ID: 33645558
[TBL] [Abstract][Full Text] [Related]
80. Ultrasound microbubble contrast and current clinical applications.
Dindyal S; Kyriakides C
Recent Pat Cardiovasc Drug Discov; 2011 Jan; 6(1):27-41. PubMed ID: 21222650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
